Novo Nordisk A/S (NVO) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $37.63
• Market Cap: $169.62B
• P/E Ratio: 10.51
• EPS: $3.63
• Dividend Yield: 0.05%
• 52-Week High: $89.43
• 52-Week Low: $37.65

Market Sentiment

Novo Nordisk A/S currently has a Neutral sentiment score of -0.12.

About Novo Nordisk A/S

Novo Nordisk A/S (NVO) is a premier global healthcare company headquartered in Bagsvaerd, Denmark, renowned for its expertise in diabetes care, obesity treatment, and hormone replacement therapies. The company stands at the forefront of innovation, utilizing advanced biotechnology and rigorous scientific research to develop and manufacture high-quality pharmaceutical products aimed at chronic disease management. As a leader in the biopharmaceutical sector, Novo Nordisk is dedicated to enhanci...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Novo Nordisk A/S and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is NVO's current dividend yield?

Novo Nordisk A/S (NVO) has a current dividend yield of 0.05%.

Does NVO pay dividends?

Yes, Novo Nordisk A/S pays dividends with a current yield of 0.05%.

What is NVO's P/E ratio?

Novo Nordisk A/S has a price-to-earnings (P/E) ratio of 10.51.

What is NVO's market cap?

Novo Nordisk A/S (NVO) has a market capitalization of $169.62B with a current stock price of $37.63.